Institutional shares held 15.2 Million
570K calls
203K puts
Total value of holdings $84.5M
$3.17M calls
$1.13M puts
Market Cap $161M
28,891,900 Shares Out.
Institutional ownership 52.6%
# of Institutions 82


Latest Institutional Activity in CADL

Top Purchases

Q3 2025
Gamma Investing LLC Shares Held: 199 ($1.11K)
Q2 2025
Portolan Capital Management, LLC Shares Held: 1.62M ($9.02M)
Q2 2025
Acorn Capital Advisors, LLC Shares Held: 2.58M ($14.3M)
Q2 2025
Two Sigma Investments, LP Shares Held: 369K ($2.05M)
Q2 2025
Geode Capital Management, LLC Shares Held: 904K ($5.03M)

Top Sells

Q3 2025
Halter Ferguson Financial Inc. Shares Held: 698K ($3.88M)
Q3 2025
Cwm, LLC Shares Held: 196 ($1.09K)
Q2 2025
Baker Bros. Advisors LP Shares Held: 355K ($1.97M)
Q2 2025
Bank Of America Corp Shares Held: 73.1K ($407K)
Q2 2025
Ubs Group Ag Shares Held: 82.2K ($457K)

About CADL

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. It also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent glioblastoma. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. The company was incorporated in 2003 and is based in Needham, Massachusetts.


Insider Transactions at CADL

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
2.66M Shares
From 14 Insiders
Grant, award, or other acquisition 1.31M shares
Open market or private purchase 1.25M shares
Exercise of conversion of derivative security 51.1K shares
Sale (or disposition) back to the issuer 50K shares
Sell / Disposition
1.99M Shares
From 6 Insiders
Open market or private sale 387K shares
Sale (or disposition) back to the issuer 1.6M shares

Track Institutional and Insider Activities on CADL

Follow Candel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CADL shares.

Notify only if

Insider Trading

Get notified when an Candel Therapeutics, Inc. insider buys or sells CADL shares.

Notify only if

News

Receive news related to Candel Therapeutics, Inc.

Track Activities on CADL